Healthcare58 min reading time

Limitations of de novo peptide sequencing in resolving sequence ambiguity

Nature
Read the full article
Mass spectrometry-based proteomics faces challenges in unambiguously identifying peptide sequences due to isobaric amino acids, missing fragment ions, and noise. Commonly, database searching limits ambiguity but cannot detect unknown proteins or isoforms, prompting proteogenomics and metaproteomics approaches.

More in Healthcare